CHEST: Nerandomilast Slows Decline in FVC in Idiopathic Pulmonary Fibrosis

THURSDAY, Oct. 23, 2025 (HealthDay News) -- For U.S. patients with idiopathic pulmonary fibrosis (IPF), nerandomilast slows the decline in forced vital capacity